| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0004 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |